Timothy Cornell > Clifford Chance > Washington DC, United States > Lawyer Profile

Clifford Chance
2001 K STREET NW
WASHINGTON DC 20006-1001
DISTRICT OF COLUMBIA
United States

Position

Tim Cornell is a partner and head of Clifford Chance’s U.S. Antitrust practice, based in Washington, DC. Building on two decades of antitrust experience, he leads the U.S. team on advising global clients on complex antitrust matters including government, civil and criminal antitrust investigations, merger clearances, the regulatory review of mergers and acquisitions, intellectual property and technology licensing, supply and distribution agreements, joint venture formation, and the adoption of antitrust best practices.

Tim has advocated on behalf of dozens of clients before the U.S. Federal Trade Commission, the U.S. Department of Justice, and the federal courts and is also a thought leader in the antitrust community on a variety of issues. Tim leads the Clifford Chance veterans affinity group, CliffVets, in the United States.

Education

United States Naval Academy (B.S.) 1992
Georgetown University Law School (J.D.) 2000
Admitted as an Attorney-at-Law in New York 2001
Joined Clifford Chance 2009
Admitted as an Attorney-at-Law in the District of Columbia 2010
Partner since 2015

Lawyer Rankings

United States > Antitrust > Merger control

Clifford Chance combines institutional relationships with major businesses and private equity funds as merger counsel with high-profile hired gun instructions from key names in fields such as healthcare, education, and consumer goods, handling cross-border strategic merger clearances as well as DOJ and FTC investigations and related litigation, with standout capabilities in acting for third parties objecting to proposed mergers and advising on multijurisdictional approvals for transactions in healthcare and life sciences. In a major development for the team, Leigh Oliver arrived from Hogan Lovells US LLP in March 2022, and promptly successfully represented UnitedHealth Group in its acquisition of Change Healthcare, a $13bn deal that faced significant scrutiny from the Antitrust Division and state attorneys general, while HSR specialist Brian Concklin was promoted to partner in May 2022. The team is led by former acting Assistant Attorney General Sharis Pozen, who has also held senior antitrust positions at the FTC and in-house, and specialises in complex merger litigation, and Timothy Cornell, a key name for multijurisdictional clearances processes and investigations. Former DOJ official Peter Mucchetti is also a key team member, with expertise in healthcare and consumer goods mandates. All lawyers mentioned are in Washington DC.